BIOVECTRA is a global CDMO with a 52 year history – and a one stop shop for our clients. Our growth, in recent years, has been explosive and we’ve made big moves into biologics in recent years. Our new mRNA and Biomanufacturing facility opens […] […]
When Dr. Marc Sauer joined BIOVECTRA as a research scientist in 2006, the company of 60 was focused on small molecules and microbial fermentation. Today, at just shy of 600 employees, BIOVECTRA is a […] […]
The location of a CDMO is always an important consideration by any sponsor organization considering its manufacturing strategy. BIOVECTRA’s facilities are located across several […] […]
For the final interview of the Road to 50 States road trip campaign, Oliver Technow and Heather Delage of BIOVECTRA met with Nigel at CPhI in Milan to discuss the company’s unique capability to offer both small and large molecule biologic products to their clients. […] […]
With over 50 years of experience, we are a forward-thinking,
North American CDMO specializing in clinical-to-commercial scale production of high-quality regulated APIs and Intermediates.